Category Archives: Cancer and neoplasms

AST/ALT-to-platelet ratio (AARPRI) predicts gynaecological cancers: a 8-years follow-up study in 653 women

Abstract Non-alcoholic fatty liver disease (NAFLD), specifically liver steatosis and fibrosis with steatohepatitis (NASH), is often associated with visceral adiposopathy, whose pathogenetic features have been proposed as tumorigenic triggers. We performed a prospective analysis in 653 metabolic women to reveal any conditions that may predict and concur to cancer development during a 8-years period of […]

Advancing the Treatment Landscape for Patients With Myeloproliferative Neoplasms

Despite recent advancements in treatments for patients with myeloproliferative neoplasms, a term encompassing several rare cancers, many challenges persist when it comes to these hematologic malignancies, primarily due to lack of uniform treatment plans for each of the classical subgroups. Neoplasms, cancerous disease, malignant tumor | Ирина Батюк – stock.adobe.com These findings were presented in […]

ASRM Posters Show Disparities in Fertility Funding, Insurance Denials

With infertility increasing equally among men and women in the United States, access and affordability are areas of concern for individuals and couples seeking fertility treatment. According to 2 posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo, disparities exist in fertility funding, with some facing insurance coverage denials […]

Dr Ben Urick Compares Value of Medically Integrated Specialty Pharmacies With Mail-Order Pharmacies

Ben Urick, PharmD, PhD of Prime Therapeutics compared the value of medically integrated dispensing (MID) specialty pharmacies to that of mail-order pharmacies in a video interview on site at AMCP Nexus. Urick discussed the topic at length as he was a speaker during the session, “Medically Integrated Dispensing Services: Creating Value for Payers and Providers” […]

Addition of Ipilimumab to Nivolumab May be ‘Unnecessary’ in Select Cancers

“These findings suggest that combination therapy with nivolumab and ipilimumab may be unnecessary in many patient populations and that nivolumab alone may deliver equivalent clinical outcomes with lower toxicity [clinical and financial] in many advanced cancers other than melanoma,” according to the authors of a study published in JAMA Oncology. There were no clinically meaningful […]

AI, ML Can Mitigate Risks, Improve Efficiency Across Managed Care Space

Artificial intelligence (AI) can be used in many ways across the managed care pharmacy space, including managing new initiative implementation, monitoring pharmacy claims, and more. A session at the Academy of Managed Care Pharmacy (AMCP)’s annual Nexus meeting showcased some of the practical uses of artificial intelligence (AI) and machine learning (ML) in the managed […]

Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma

ABSTRACT Predominantly autoimmune in origin, severe normochromic, normocytic anemia with reticulocytopenia in the setting of the normal production of leukocytes and megakaryocytic lineages is known as pure red cell aplasia (PRCA), which is unlike aplastic anemia in which all lineages are affected due to a stem cell defect. PRCA can be primary (such as autoimmune) […]

Call for Cultural Considerations When Screening Oocyte Donors and Gestational Carriers

Professional Medical Evaluation | Image Credit: Blue Planet Studio – stock.adobe.com Wiyatta Fahnbulleh, PsyD, and Pamela Blackwell, PsyD, LMSW, led the discussion, “Cultural Diversity and Considerations for Psychological Assessment When Screening Oocyte Donors and Gestational Carriers: What are the Limitations of Our Data?” during the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & […]